Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

How much glucose is in Sweet Cheeks oral glucose gel?

Journal of Perinatology volume 43, pages 1181–1182 (2023)Cite this article

Subjects

Oral glucose gel is used to treat neonatal hypoglycemia (NH), an important health issue for newborns. Previously, our team reported the results of a laboratory study in which we measured the concentrations of two commonly used glucose gels, Glutose 15 and Insta-Glucose, and found percent differences of 39.6% to 79.6% depending on which part of the tube the dose was extracted from [1]. After we conducted the previous study, a new glucose gel, Sweet Cheeks (Dandle Lion Medical, Danbury, CT), became available. This product is neonate-specific and packaged in 3 mL syringes. There are no published studies on the glucose consistency in this new product even though many hospitals are using it as an alternative to the adult diabetes care products that we previously tested.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Stanzo K, Kumar V, Chiruvolu A, Cipher DJ. How much glucose is in the gel used to treat neonatal hypoglycemia? J Obstet Gynecol Neonatal Nurs. 2022;51:218–24.

    Article  PubMed  Google Scholar 

  2. Burakevych N, McKinlay C, Harris D, Alsweiler J, Harding J. Factors influencing glycaemic stability after neonatal hypoglycemia and relationship to neurodevelopmental outcome. Sci Rep. 2019;9:8132.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Funding

This study was funded by a grant received from the Baylor Scott and White Health Foundation.

Author information

Authors and Affiliations

  1. Baylor Scott and White Health, 5252 West University Drive, McKinney, TX, 75071, USA

    Karen Stanzo

  2. Quest Diagnostics | med fusion, Lewisville, TX, 75067, USA

    Vivek Kumar & Alice Gallegos

  3. Baylor University Medical Center, Dallas, TX, USA

    Arpitha Chiruvolu

  4. Pediatrix Medical Group of Dallas, Dallas, TX, USA

    Arpitha Chiruvolu

Authors
  1. Karen Stanzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivek Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alice Gallegos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arpitha Chiruvolu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KS was responsible for the original conception of the study, securing the funding, conducting the literature review, creating the discussion section and the reference list, and writing the final report. VK was responsible for designing the laboratory study and analyzing the data. AG performed the laboratory tests. AC assisted with funding procurement and provided feedback on the clinical implications of the findings.

Corresponding author

Correspondence to Karen Stanzo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stanzo, K., Kumar, V., Gallegos, A. et al. How much glucose is in Sweet Cheeks oral glucose gel?. J Perinatol 43, 1181–1182 (2023). https://doi.org/10.1038/s41372-023-01670-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-023-01670-z

Search

Advanced search

Quick links